Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reliability assessment of the definition of ultrasound enthesitis in SpA: results of a large, multicentre, international, web-based study.
Di Matteo A, Cipolletta E, Destro Castaniti GM, Smerilli G, Airoldi C, Aydin SZ, Becciolini A, Bonfiglioli K, Bruns A, Carrara G, Cazenave T, Ciapetti A, Cosatti MA, de Agustín JJ, Di Carlo M, Di Donato E, Di Geso L, Duran E, Elliott A, Estrach C, Farisogulları B, Fiorenza A, Fodor D, Gabba A, Hernández-Díaz C, Huang F, Hurnakova J, Li L, Jesus D, Karadag O, Martire MV, Massarotti M, Michelena X, Musca AA, Nair J, Okano T, Papalopoulos I, Rosemffet M, Rovisco J, Rozza D, Salaffi F, Satulu I, Scioscia C, Scirè CA, Sun F, Tamas MM, Tanimura S, Ventura-Rios L, Voulgari PV, Vreju FA, Vukatana G, Wong E, Yang J, Zacariaz Hereter J, Zanetti A, Grassi W, Filippucci E. Di Matteo A, et al. Among authors: farisogullari b. Rheumatology (Oxford). 2022 Nov 28;61(12):4863-4874. doi: 10.1093/rheumatology/keac162. Rheumatology (Oxford). 2022. PMID: 35293988
Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: real-life results from the HURBIO registry.
Bilgin E, Farisoğulları B, Armağan B, Sarı A, Yardımcı GK, Bölek EÇ, Kılıç L, Akdoğan A, Bilgen ŞA, Karadağ Ö, Ertenli Aİ, Kiraz S, Kalyoncu U. Bilgin E, et al. Among authors: farisogullari b. Clin Exp Rheumatol. 2020 Jul-Aug;38(4):609-614. Epub 2019 Aug 14. Clin Exp Rheumatol. 2020. PMID: 31498074
Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience.
Bilgin E, Ceylan F, Duran E, Farisoğullari B, Bölek EÇ, Yardimci GK, Kiliç L, Akdoğan A, Karadağ Ö, Apraş Bilgen ŞŞ, Kiraz S, Ertenli Aİ, Kalyoncu U. Bilgin E, et al. Among authors: farisogullari b. Turk J Med Sci. 2021 Feb 26;51(1):297-308. doi: 10.3906/sag-2007-123. Turk J Med Sci. 2021. PMID: 32979899 Free PMC article.
Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry.
Farisoğulları B, Yardımcı GK, Sarı A, Bilgin E, Bölek EÇ, Duran E, Kılıç L, Akdoğan A, Karadağ Ö, Apraş Bilgen Ş, Ertenli Aİ, Kiraz S, Kalyoncu U. Farisoğulları B, et al. Clin Exp Rheumatol. 2022 Jan;40(1):112-119. doi: 10.55563/clinexprheumatol/uxcofr. Epub 2021 Feb 25. Clin Exp Rheumatol. 2022. PMID: 33635221 Free article.
Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry results.
Ayan G, Farisogulları B, Bilgin E, Bolek EC, KübraYardımcı G, Duran E, Ozsoy Z, Uzun GS, Kilic L, Akdoğan A, Karadag O, Bilgen ŞA, Kiraz S, Ertenli Aİ, Kalyoncu U. Ayan G, et al. Among authors: farisogullari b. Clin Rheumatol. 2022 May;41(5):1439-1446. doi: 10.1007/s10067-021-06012-y. Epub 2022 Jan 27. Clin Rheumatol. 2022. PMID: 35088209
Comprehensive assessment and outcomes of patients with chronic periaortitis.
Yardimci GK, Ardali Düzgün S, Farisogullari B, Bölek EC, Eldem FG, Erden A, Kiliç L, Kösemehmetoglu K, Sağlam A, Peynircioğlu B, Akdoğan B, Hazirolan T, Karadag O. Yardimci GK, et al. Among authors: farisogullari b. Clin Exp Rheumatol. 2022 May;40(4):801-810. doi: 10.55563/clinexprheumatol/araba3. Epub 2022 Mar 18. Clin Exp Rheumatol. 2022. PMID: 35349413 Free article.
27 results